Deanna Horner, EVP of Enterprise DIRECT Strategy at EVERSANA, explains which therapeutic areas will lead DTP adoption and her five-year outlook for the model.
Deanna Horner
Advertisement
Deanna Horner is executive vice president, Enterprise DIRECT Strategy, at EVERSANA.
Articles by Deanna Horner
Deanna Horner, EVP of Enterprise DIRECT Strategy at EVERSANA, explains how real-time data generated through direct-to-patient models are shaping pharma's commercial decisions.
Deanna Horner, EVP of Enterprise DIRECT Strategy at EVERSANA, breaks down what's fueling pharma's embrace of direct-to-patient models.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Retatrutide's Black Market Problem, CSafe's Mobile App, BMS's Houston Bet
2
Supply Chain Signal: Three Tariff Deadlines Reshaping Pharma Manufacturing
3
The Role of Artificial Intelligence In Access
4
DSCSA Can Trace a Package. It Cannot Tell Whether the Next One Will Arrive.
5